Hepatocellular carcinoma drug resistance models

Abstract Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Although drug therapy has been well developed and applied, its clinical efficacy is limited due to primary or acquired drug resistance in most HCC patients. Therefore, it is of great clinical signi...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaolu Xie, Yaomin Wang, Ziyi Wang, Lei Zhang, Jun Li, Yaling Li
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-025-03821-y
Tags: Add Tag
No Tags, Be the first to tag this record!